Anticoagulant Pharmacodynamics of Tinzaparin Following 175 IU/kg Subcutaneous Administration to Healthy Volunteers-Reference-Cited by-同舟云学术

Anticoagulant Pharmacodynamics of Tinzaparin Following 175 IU/kg Subcutaneous Administration to Healthy Volunteers

Published:2001-02 Issue:4 Volume:101 Page:243-254
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Barrett Jeffrey S.,Hainer James W.,Kornhauser David M.,Gaskill James L.,Hua Tsushung A.,Sprogel Per,Johansen Kristen,van Lier J.J.,Knebel William,Pieniaszek Henry J.

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. Production and chemical processing of low molecular weight heparins;Linhardt;Semin Thromb Hemostasis,1999

2. Subcutaneous low-molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis;Hull;N Engl J Med,1992

3. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism;Simonneau;N Engl J Med,1997

4. A comparison of subcutaneous low-molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation;Hull;N Engl J Med,1993

5. Prevention of perioperative deep vein thrombosis in general surgery: a multicenter double blind study comparing two doses of logiparin and standard heparin;Leizorovicz;Br J Surg,1991

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses;European Journal of Clinical Pharmacology;2022-07-23

2. Gerinnungsdiagnostik im klinischen Alltag – Teil 2;Die Innere Medizin;2022-05-19

3. Different combination strategies for prophylaxis of venous thromboembolism in patients: A prospective multicenter randomized controlled study;Scientific Reports;2018-05-29

4. Recent advances in mass spectrometry analysis of low molecular weight heparins;Chinese Chemical Letters;2018-01

5. The Role of Tinzaparin in Oncology;Clinical and Applied Thrombosis/Hemostasis;2017-10-31